VEDOLIZUMAB

VEDOLIZUMAB was reported 86821 times

VEDOLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THERAPEUTIC REACTION TIME DECREASED 2756 0.9438
1 VAGINAL FLATULENCE 190 0.6271
2 GASTROINTESTINAL ANASTOMOTIC STENOSIS 37 0.3895
3 COLITIS ULCERATIVE 15710 0.3511
4 LOSS OF THERAPEUTIC RESPONSE 1041 0.3262
5 ILEOCAECAL RESECTION 107 0.3110
6 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 174 0.3102
7 STEROID DEPENDENCE 251 0.2859
8 MUCOUS STOOLS 1319 0.2660
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 166 0.2485
10 CATHETER SITE INJURY 50 0.2347
11 DEFAECATION URGENCY 1530 0.2181
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 435 0.2097
13 PROCTOCOLECTOMY 62 0.2033
14 ARTHRITIS ENTEROPATHIC 65 0.1994
15 FREQUENT BOWEL MOVEMENTS 5300 0.1960
16 DISLOCATION OF VERTEBRA 440 0.1927
17 INTESTINAL ANASTOMOSIS COMPLICATION 51 0.1882
18 GASTROINTESTINAL STOMA OUTPUT INCREASED 87 0.1855
19 COLON DYSPLASIA 53 0.1853
20 FAECAL CALPROTECTIN INCREASED 585 0.1845
21 CATARRH 165 0.1825
22 POUCHITIS 157 0.1823
23 X-RAY ABNORMAL 302 0.1687
24 FEMALE GENITAL TRACT FISTULA 285 0.1668
25 BILE ACID MALABSORPTION 47 0.1667
26 GASTROINTESTINAL MUCOSA HYPERAEMIA 48 0.1622
27 COLORECTAL ADENOMA 52 0.1610
28 RECTAL TENESMUS 200 0.1605
29 TERMINAL ILEITIS 97 0.1580
30 ILEECTOMY 53 0.1573
31 RECTAL STENOSIS 51 0.1532
32 STOMAL HERNIA 56 0.1526
33 STOMA SITE ABSCESS 37 0.1523
34 PROCTITIS 414 0.1476
35 LARGE INTESTINAL STENOSIS 295 0.1474
36 PSEUDOPOLYP 53 0.1472
37 ANASTOMOTIC ULCER 67 0.1457
38 FAECAL VOLUME DECREASED 69 0.1437
39 NIPPLE SWELLING 36 0.1434
40 INTESTINAL ANASTOMOSIS 92 0.1429
41 LUPUS VULGARIS 180 0.1429
42 ILEAL STENOSIS 252 0.1417
43 ANAL STENOSIS 73 0.1370
44 GASTROINTESTINAL SCARRING 98 0.1352
45 COLECTOMY TOTAL 75 0.1344
46 BACTERIAL VULVOVAGINITIS 37 0.1280
47 FAECES SOFT 925 0.1271
48 CHOLANGITIS SCLEROSING 258 0.1255
49 FAECAL CALPROTECTIN ABNORMAL 51 0.1229
50 DEEP VEIN THROMBOSIS POSTOPERATIVE 243 0.1213
51 PROCTITIS ULCERATIVE 73 0.1211
52 ILEAL ULCER 120 0.1186
53 INTESTINAL STENOSIS 493 0.1168
54 SERONEGATIVE ARTHRITIS 132 0.1152
55 RETINITIS 199 0.1151
56 ANAL ABSCESS 606 0.1123
57 HAEMATOCHEZIA 6172 0.1117
58 POOR VENOUS ACCESS 1125 0.1086
59 ILEOSTOMY 275 0.1076
60 COLECTOMY 601 0.1063
61 SWOLLEN JOINT COUNT INCREASED 338 0.1059
62 ANASTOMOTIC STENOSIS 39 0.1048
63 ANAL FISTULA 539 0.1009
64 DRUG LEVEL DECREASED 1016 0.0997
65 GASTROINTESTINAL MICROORGANISM OVERGROWTH 35 0.0994
66 RECTAL ABSCESS 163 0.0971
67 BURNS SECOND DEGREE 170 0.0968
68 FISTULA OF SMALL INTESTINE 40 0.0957
69 PORPHYRIA ACUTE 137 0.0955
70 SMALL INTESTINAL STENOSIS 99 0.0930
71 RHEUMATIC FEVER 413 0.0926
72 STRESS AT WORK 104 0.0921
73 INTESTINAL FISTULA 129 0.0916
74 DYSCHEZIA 278 0.0910
75 ABSCESS INTESTINAL 193 0.0896
76 ANAL FISSURE 463 0.0862
77 SHORT-BOWEL SYNDROME 56 0.0860
78 PREGNANCY 1699 0.0848
79 GASTROINTESTINAL INFLAMMATION 633 0.0807
80 INFECTED FISTULA 42 0.0784
81 GASTROINTESTINAL WALL THICKENING 117 0.0781
82 SMALL INTESTINAL RESECTION 89 0.0763
83 RHEUMATOID FACTOR POSITIVE 441 0.0763
84 CAMPYLOBACTER INFECTION 63 0.0758
85 RADICULOPATHY 194 0.0735
86 ABDOMINAL MASS 195 0.0727
87 GASTROINTESTINAL BACTERIAL INFECTION 82 0.0717
88 COLONIC ABSCESS 61 0.0713
89 LARGE INTESTINAL ULCER 193 0.0710
90 NEUROGENIC SHOCK 38 0.0701
91 ENTEROCUTANEOUS FISTULA 60 0.0680
92 SPONDYLOARTHROPATHY 40 0.0667
93 GASTROENTERITIS ESCHERICHIA COLI 36 0.0658
94 FACET JOINT SYNDROME 212 0.0651
95 REMISSION NOT ACHIEVED 40 0.0643
96 LARGE INTESTINE POLYP 440 0.0635
97 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 454 0.0633
98 CLOSTRIDIUM DIFFICILE INFECTION 1382 0.0632
99 ANAL INCONTINENCE 563 0.0625
100 FISTULA 696 0.0619
101 GASTROINTESTINAL BACTERIAL OVERGROWTH 37 0.0617
102 C-REACTIVE PROTEIN 56 0.0604
103 INTESTINAL ULCER 96 0.0604
104 PROCTALGIA 387 0.0601
105 HELICOBACTER INFECTION 616 0.0599
106 RECTAL HAEMORRHAGE 2565 0.0596
107 MATERNAL EXPOSURE DURING BREAST FEEDING 242 0.0596
108 CYTOMEGALOVIRUS COLITIS 137 0.0595
109 SOCIAL PROBLEM 246 0.0594
110 BONE EROSION 210 0.0593
111 DISCOURAGEMENT 137 0.0585
112 DUODENAL ULCER PERFORATION 434 0.0583
113 ANAL INFLAMMATION 37 0.0579
114 MUSCLE INJURY 480 0.0579
115 ANAL HAEMORRHAGE 154 0.0549
116 GASTROINTESTINAL VIRAL INFECTION 57 0.0548
117 PUSTULAR PSORIASIS 186 0.0541
118 GASTROINTESTINAL STOMA COMPLICATION 85 0.0540
119 RECTAL FISSURE 34 0.0540
120 DIARRHOEA HAEMORRHAGIC 503 0.0538
121 FISTULA DISCHARGE 66 0.0523
122 COLOSTOMY 102 0.0519
123 ABDOMINAL LYMPHADENOPATHY 45 0.0518
124 FOLLICULITIS 542 0.0516
125 WOUND INFECTION 559 0.0510
126 DRUG SPECIFIC ANTIBODY 69 0.0504
127 HYPOPNOEA 173 0.0498
128 STENOSIS 93 0.0495
129 SERUM FERRITIN DECREASED 84 0.0486
130 INTESTINAL RESECTION 261 0.0485
131 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 315 0.0485
132 CHRONIC SINUSITIS 176 0.0468
133 ABDOMINAL ABSCESS 206 0.0466
134 ANAL ULCER 38 0.0465
135 ABDOMINAL ADHESIONS 146 0.0462
136 ENTEROVESICAL FISTULA 35 0.0461
137 C-REACTIVE PROTEIN ABNORMAL 296 0.0461
138 FAECES HARD 179 0.0460
139 GASTROENTERITIS SALMONELLA 38 0.0457
140 GASTROINTESTINAL FISTULA 40 0.0457
141 RECTAL DISCHARGE 168 0.0456
142 INTESTINAL MASS 62 0.0453
143 HAND DEFORMITY 592 0.0451
144 ERYTHEMA NODOSUM 155 0.0441
145 HYPERCHOLESTEROLAEMIA 426 0.0441
146 DRUG SPECIFIC ANTIBODY PRESENT 284 0.0436
147 PYODERMA GANGRENOSUM 157 0.0436
148 PERIPHERAL VENOUS DISEASE 178 0.0435
149 BRONCHIECTASIS 293 0.0434
150 GRIP STRENGTH DECREASED 377 0.0428
151 ALCOHOL POISONING 111 0.0414
152 INTESTINAL OPERATION 65 0.0410
153 GASTROINTESTINAL INFECTION 368 0.0410
154 RECTAL ULCER 48 0.0409
155 PEMPHIGUS 510 0.0408
156 GROIN ABSCESS 48 0.0407
157 ABNORMAL FAECES 330 0.0402
158 STENOTROPHOMONAS INFECTION 54 0.0398
159 INTESTINAL DILATATION 53 0.0397
160 JOINT RANGE OF MOTION DECREASED 527 0.0393
161 DRUG EFFECT LESS THAN EXPECTED 579 0.0390
162 RASH VESICULAR 186 0.0384
163 COLITIS MICROSCOPIC 180 0.0380
164 INFLAMMATORY BOWEL DISEASE 371 0.0379
165 LUPUS-LIKE SYNDROME 341 0.0376
166 INTESTINAL OBSTRUCTION 1413 0.0375
167 WALKING AID USER 247 0.0374
168 HAEMORRHOIDS 726 0.0372
169 INCISIONAL HERNIA 51 0.0367
170 COLITIS 1380 0.0364
171 PERICARDITIS 607 0.0361
172 IMPAIRED QUALITY OF LIFE 518 0.0360
173 DYSPLASIA 43 0.0358
174 VEIN RUPTURE 60 0.0358
175 BREAST CANCER STAGE III 231 0.0356
176 PERIRECTAL ABSCESS 39 0.0352
177 SPONDYLITIS 126 0.0346
178 LARGE INTESTINE INFECTION 42 0.0341
179 IRRITABLE BOWEL SYNDROME 731 0.0341
180 INFUSION SITE EXTRAVASATION 211 0.0339
181 PRODUCT AVAILABILITY ISSUE 760 0.0333
182 SALMONELLOSIS 56 0.0332
183 RECTAL PROLAPSE 40 0.0331
184 SMALL INTESTINAL OBSTRUCTION 406 0.0330
185 IRON DEFICIENCY 147 0.0327
186 ANORECTAL DISCOMFORT 172 0.0323
187 ABDOMINAL PAIN 7505 0.0322
188 APPENDICECTOMY 115 0.0322
189 COLON OPERATION 38 0.0317
190 GASTROINTESTINAL OBSTRUCTION 76 0.0315
191 PRODUCT TEMPERATURE EXCURSION ISSUE 162 0.0315
192 ABDOMINAL HERNIA 142 0.0311
193 ABSCESS 494 0.0309
194 LOWER RESPIRATORY TRACT INFECTION 1393 0.0306
195 RHINITIS 245 0.0304
196 BILE DUCT STENOSIS 36 0.0300
197 GENERAL SYMPTOM 225 0.0300
198 INTESTINAL POLYP 49 0.0298
199 SACROILIITIS 56 0.0296
200 APPENDICITIS 277 0.0296
201 SYNOVITIS 528 0.0293
202 BLOOD IRON DECREASED 347 0.0292
203 LIP DRY 265 0.0291
204 ENTERITIS 186 0.0290
205 INJECTION SITE DISCHARGE 154 0.0286
206 STOMA SITE HAEMORRHAGE 44 0.0286
207 ANORECTAL DISORDER 56 0.0281
208 JOINT DISLOCATION 295 0.0279
209 INFUSION SITE BRUISING 60 0.0278
210 AUTOIMMUNE DISORDER 270 0.0277
211 HEPATIC INFECTION 35 0.0274
212 THERAPY NON-RESPONDER 1228 0.0273
213 FIBROMYALGIA 649 0.0267
214 GLOSSODYNIA 597 0.0266
215 GASTROINTESTINAL PAIN 293 0.0266
216 INJECTION SITE EXTRAVASATION 326 0.0264
217 LATENT TUBERCULOSIS 55 0.0262
218 FOOD POISONING 138 0.0257
219 ADENOCARCINOMA OF COLON 48 0.0256
220 OFF LABEL USE 22425 0.0256
221 ABSCESS LIMB 109 0.0256
222 BREAST CANCER STAGE II 212 0.0255
223 DRUG LEVEL BELOW THERAPEUTIC 140 0.0254
224 APHTHOUS ULCER 196 0.0252
225 NASAL DISCHARGE DISCOLOURATION 34 0.0246
226 ABDOMINAL PAIN LOWER 619 0.0245
227 PRODUCT DISTRIBUTION ISSUE 225 0.0242
228 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 34 0.0241
229 SUBILEUS 50 0.0240
230 INFLAMMATORY MARKER INCREASED 118 0.0238
231 DIVERTICULUM INTESTINAL 104 0.0238
232 GINGIVAL PAIN 189 0.0237
233 INFREQUENT BOWEL MOVEMENTS 59 0.0237
234 PULMONARY FIBROSIS 452 0.0235
235 OBSTRUCTION 94 0.0235
236 GASTROENTERITIS 343 0.0235
237 POSTOPERATIVE WOUND INFECTION 158 0.0234
238 POST PROCEDURAL INFECTION 190 0.0233
239 IRON DEFICIENCY ANAEMIA 215 0.0233
240 PAROSMIA 175 0.0232
241 ENTERITIS INFECTIOUS 39 0.0229
242 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4078 0.0226
243 GASTROINTESTINAL ULCER 50 0.0225
244 SECONDARY ADRENOCORTICAL INSUFFICIENCY 34 0.0225
245 WOUND 622 0.0222
246 UMBILICAL HERNIA 103 0.0220
247 MYOSITIS 196 0.0218
248 EXOSTOSIS 199 0.0218
249 VAGINAL DISCHARGE 220 0.0217
250 HIP ARTHROPLASTY 332 0.0217
251 IMPAIRED WORK ABILITY 459 0.0215
252 SYSTEMIC LUPUS ERYTHEMATOSUS 762 0.0214
253 SHOULDER FRACTURE 35 0.0214
254 ABDOMINAL RIGIDITY 58 0.0214
255 ADENOVIRUS INFECTION 62 0.0214
256 DRUG TOLERANCE DECREASED 60 0.0213
257 CARDIAC MURMUR 183 0.0211
258 ABDOMINAL TENDERNESS 104 0.0209
259 WEIGHT FLUCTUATION 219 0.0209
260 IMPAIRED HEALING 686 0.0209
261 BOWEL MOVEMENT IRREGULARITY 159 0.0207
262 LOWER LIMB FRACTURE 398 0.0207
263 INTRA-ABDOMINAL FLUID COLLECTION 37 0.0206
264 THERAPY PARTIAL RESPONDER 316 0.0202
265 ORAL CANDIDIASIS 264 0.0200
266 GASTROINTESTINAL SOUNDS ABNORMAL 99 0.0200
267 DISABILITY 393 0.0199
268 FLATULENCE 1123 0.0198
269 RED BLOOD CELL SEDIMENTATION RATE INCREASED 218 0.0197
270 FOOD INTOLERANCE 72 0.0196
271 BURSITIS 238 0.0196
272 APPENDICITIS PERFORATED 48 0.0189
273 EXPOSURE VIA BREAST MILK 75 0.0188
274 INFECTIOUS MONONUCLEOSIS 42 0.0187
275 NIPPLE PAIN 38 0.0186
276 HEPATIC CIRRHOSIS 349 0.0186
277 THERAPEUTIC PRODUCT EFFECT DECREASED 830 0.0185
278 TUBULOINTERSTITIAL NEPHRITIS 346 0.0184
279 UVEITIS 250 0.0184
280 TYPE 2 DIABETES MELLITUS 620 0.0184
281 MOUTH ULCERATION 385 0.0183
282 LIVER INJURY 447 0.0182
283 GASTROINTESTINAL MOTILITY DISORDER 97 0.0181
284 TREATMENT FAILURE 1498 0.0181
285 VITAMIN B12 DECREASED 51 0.0177
286 SCIATICA 282 0.0177
287 HAEMATOLOGICAL INFECTION 43 0.0176
288 SUSPECTED COVID-19 58 0.0176
289 BLOOD PRESSURE DIASTOLIC INCREASED 80 0.0173
290 FOOT DEFORMITY 192 0.0173
291 PHARYNGITIS STREPTOCOCCAL 186 0.0172
292 MACULAR DEGENERATION 203 0.0170
293 PRESCRIBED OVERDOSE 327 0.0169
294 IMMUNE-MEDIATED ENTEROCOLITIS 62 0.0168
295 BODY TEMPERATURE DECREASED 165 0.0167
296 INTESTINAL PERFORATION 188 0.0167
297 C-REACTIVE PROTEIN INCREASED 605 0.0166
298 HAEMORRHOIDAL HAEMORRHAGE 81 0.0166
299 SPINAL FUSION SURGERY 67 0.0165
300 CHRONIC GASTRITIS 37 0.0164
301 POLYP 107 0.0163
302 LIVER ABSCESS 53 0.0163
303 CLOSTRIDIUM TEST POSITIVE 36 0.0163
304 MATERNAL EXPOSURE TIMING UNSPECIFIED 61 0.0162
305 BACK DISORDER 263 0.0162
306 TONSILLITIS 84 0.0161
307 VITAMIN B12 DEFICIENCY 65 0.0160
308 CERVICAL DYSPLASIA 35 0.0160
309 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 34 0.0160
310 HERNIA 307 0.0159
311 NEPHROLITHIASIS 728 0.0159
312 EAR INFECTION 421 0.0158
313 GAIT INABILITY 528 0.0158
314 ABDOMINAL DISTENSION 1637 0.0157
315 FAECES DISCOLOURED 340 0.0157
316 KNEE ARTHROPLASTY 329 0.0156
317 INGUINAL HERNIA 95 0.0156
318 BLOOD ALBUMIN DECREASED 123 0.0155
319 GASTRIC POLYPS 35 0.0155
320 MALNUTRITION 171 0.0153
321 CLOSTRIDIUM DIFFICILE COLITIS 162 0.0153
322 INFUSION RELATED REACTION 1012 0.0153
323 PRESCRIBED UNDERDOSE 302 0.0151
324 BILE DUCT STONE 48 0.0151
325 NO ADVERSE EVENT 2725 0.0150
326 ENDOMETRIOSIS 71 0.0149
327 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 106 0.0148
328 ATYPICAL PNEUMONIA 44 0.0147
329 DELIRIUM 500 0.0144
330 CUSHINGOID 46 0.0143
331 JOINT STIFFNESS 375 0.0143
332 DIVERTICULITIS 391 0.0141
333 EAR CONGESTION 38 0.0140
334 NASOPHARYNGITIS 2546 0.0138
335 DECREASED IMMUNE RESPONSIVENESS 135 0.0137
336 SERUM SICKNESS 38 0.0136
337 DIARRHOEA 8782 0.0136
338 ANIMAL BITE 36 0.0135
339 LIVER FUNCTION TEST INCREASED 289 0.0134
340 OBESITY 214 0.0134
341 NIGHT SWEATS 429 0.0133
342 ABDOMINAL INFECTION 34 0.0133
343 SINUSITIS 1360 0.0133
344 PRODUCT DOSE OMISSION ISSUE 3868 0.0131
345 SUBCUTANEOUS ABSCESS 63 0.0131
346 GASTROENTERITIS VIRAL 237 0.0131
347 SKIN CANCER 282 0.0131
348 DISCOMFORT 792 0.0130
349 LARGE INTESTINE PERFORATION 90 0.0129
350 ARTHRITIS 1016 0.0129
351 BLOOD PRESSURE INCREASED 1963 0.0128
352 PARAESTHESIA ORAL 185 0.0128
353 PHARYNGITIS 157 0.0126
354 ACUTE GRAFT VERSUS HOST DISEASE 57 0.0124
355 BASAL CELL CARCINOMA 194 0.0124
356 KIDNEY INFECTION 244 0.0124
357 COVID-19 2166 0.0123
358 LIVE BIRTH 103 0.0123
359 INFLAMMATION 635 0.0123
360 AUTOIMMUNE HAEMOLYTIC ANAEMIA 42 0.0122
361 HEPATIC ENZYME INCREASED 835 0.0122
362 ROAD TRAFFIC ACCIDENT 512 0.0122
363 EYE INFLAMMATION 116 0.0121
364 FUNCTIONAL GASTROINTESTINAL DISORDER 42 0.0121
365 COLON CANCER 181 0.0121
366 CLOSTRIDIAL INFECTION 41 0.0121
367 ESCHERICHIA URINARY TRACT INFECTION 51 0.0120
368 CACHEXIA 61 0.0118
369 PSORIATIC ARTHROPATHY 480 0.0118
370 INFLUENZA 1318 0.0118
371 LUNG CANCER METASTATIC 34 0.0118
372 ILLNESS 1215 0.0118
373 GASTROINTESTINAL DISORDER 1052 0.0117
374 DUODENITIS 36 0.0117
375 WEIGHT DECREASED 3256 0.0117
376 FRUSTRATION TOLERANCE DECREASED 94 0.0116
377 BLOOD MAGNESIUM DECREASED 100 0.0116
378 ARTHROPATHY 643 0.0116
379 ARTHRALGIA 4810 0.0116
380 GROWTH RETARDATION 34 0.0115
381 SURGERY 676 0.0115
382 FEAR OF INJECTION 82 0.0115
383 PORTAL HYPERTENSION 35 0.0113
384 VASCULAR DEVICE INFECTION 51 0.0112
385 OSTEOARTHRITIS 475 0.0112
386 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 538 0.0112
387 RECTAL CANCER 34 0.0111
388 PROCEDURAL PAIN 303 0.0109
389 ABDOMINAL DISCOMFORT 1829 0.0109
390 OEDEMA 589 0.0108
391 TOOTH INFECTION 143 0.0108
392 LIVER TRANSPLANT 39 0.0107
393 MALABSORPTION 56 0.0107
394 BLOOD CHOLESTEROL INCREASED 498 0.0107
395 CATARACT 636 0.0107
396 VIRAL INFECTION 354 0.0106
397 OSTEOPOROSIS 436 0.0106
398 TOOTH ABSCESS 107 0.0105
399 CYTOMEGALOVIRUS INFECTION 174 0.0105
400 BLOOD PRESSURE DECREASED 693 0.0104
401 FURUNCLE 82 0.0103
402 INFUSION SITE SWELLING 65 0.0103
403 CHOLANGITIS 64 0.0103
404 CONSTIPATION 2248 0.0103
405 BRONCHITIS 762 0.0103
406 ABDOMINAL PAIN UPPER 2118 0.0103
407 WHEEZING 609 0.0103
408 BLISTER 574 0.0102
409 ESCHERICHIA INFECTION 84 0.0102
410 VAGINAL INFECTION 48 0.0102
411 INFECTION 1470 0.0101
412 DYSPEPSIA 991 0.0101
413 PYELONEPHRITIS 87 0.0100
414 MALAISE 4398 0.0100
415 INFUSION SITE PAIN 129 0.0100
416 MALIGNANT MELANOMA 133 0.0099
417 SKIN INFECTION 110 0.0098
418 OROPHARYNGEAL PAIN 907 0.0098
419 AUTOIMMUNE HEPATITIS 68 0.0098
420 PARANASAL SINUS DISCOMFORT 37 0.0098
421 AMNESIA 633 0.0097
422 PANCREATITIS 514 0.0097
423 PRODUCT ADMINISTRATION ERROR 195 0.0096
424 ABORTION SPONTANEOUS 386 0.0096
425 FLANK PAIN 90 0.0096
426 STREPTOCOCCAL INFECTION 53 0.0095
427 UPPER RESPIRATORY TRACT INFECTION 436 0.0094
428 VITAMIN D DEFICIENCY 92 0.0094
429 HOSPITALISATION 1439 0.0094
430 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 666 0.0094
431 BODY TEMPERATURE INCREASED 191 0.0094
432 RESPIRATORY RATE INCREASED 83 0.0093
433 HYPOPHAGIA 238 0.0093
434 HORDEOLUM 40 0.0092
435 QUALITY OF LIFE DECREASED 124 0.0092
436 PNEUMONIA 2982 0.0092
437 MIGRAINE 879 0.0092
438 SECRETION DISCHARGE 115 0.0092
439 THYROID MASS 35 0.0091
440 ULCER 145 0.0091
441 POST PROCEDURAL COMPLICATION 175 0.0091
442 LOCALISED INFECTION 219 0.0090
443 ANKYLOSING SPONDYLITIS 118 0.0089
444 CONCUSSION 69 0.0089
445 AUTISM SPECTRUM DISORDER 49 0.0089
446 STOMATITIS 537 0.0088
447 ILEUS 110 0.0088
448 PALLOR 240 0.0088
449 PYREXIA 3048 0.0088
450 LIVER DISORDER 387 0.0087
451 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 53 0.0087
452 RED CELL DISTRIBUTION WIDTH INCREASED 36 0.0087
453 HEART RATE INCREASED 855 0.0086
454 OVARIAN CYST 86 0.0086
455 LIGAMENT RUPTURE 38 0.0086
456 CYSTITIS 273 0.0086
457 INJURY 602 0.0086
458 NASAL CONGESTION 502 0.0085
459 POLYARTHRITIS 45 0.0085
460 OESOPHAGEAL CANDIDIASIS 34 0.0085
461 MUSCULOSKELETAL STIFFNESS 746 0.0085
462 CHOLECYSTECTOMY 97 0.0085
463 EAR PAIN 165 0.0085
464 BACK INJURY 92 0.0085
465 INCORRECT DRUG ADMINISTRATION RATE 36 0.0085
466 CONTUSION 813 0.0084
467 BLEPHAROSPASM 53 0.0084
468 GESTATIONAL DIABETES 40 0.0084
469 DRUG-INDUCED LIVER INJURY 262 0.0083
470 LYMPHOMA 129 0.0083
471 CELLULITIS 418 0.0083
472 PULMONARY MASS 123 0.0082
473 HAEMOGLOBIN ABNORMAL 53 0.0082
474 HEART RATE DECREASED 289 0.0082
475 FATIGUE 6395 0.0082
476 UTERINE LEIOMYOMA 60 0.0082
477 EYE INFECTION 92 0.0081
478 SKIN LACERATION 88 0.0081
479 CHOLELITHIASIS 265 0.0081
480 SKIN WARM 47 0.0081
481 ORGANISING PNEUMONIA 40 0.0081
482 HAND FRACTURE 57 0.0080
483 MOBILITY DECREASED 576 0.0080
484 EPSTEIN-BARR VIRUS INFECTION 50 0.0080
485 PLATELET COUNT INCREASED 104 0.0080
486 BREAST CANCER FEMALE 213 0.0080
487 INFLUENZA LIKE ILLNESS 656 0.0080
488 SQUAMOUS CELL CARCINOMA OF SKIN 48 0.0079
489 ROSACEA 37 0.0079
490 PERIPHERAL SWELLING 1214 0.0079
491 FAECALOMA 43 0.0078
492 GENERAL PHYSICAL HEALTH DETERIORATION 907 0.0078
493 HEPATIC ENZYME ABNORMAL 39 0.0078
494 DEVICE RELATED INFECTION 120 0.0078
495 LUNG DISORDER 382 0.0078
496 HEPATIC STEATOSIS 144 0.0077
497 BRAIN FOG 121 0.0077
498 JOINT SWELLING 929 0.0077
499 THERAPEUTIC PRODUCT EFFECT DELAYED 35 0.0077
500 DECREASED APPETITE 1772 0.0076
501 POOR QUALITY SLEEP 164 0.0076
502 PHLEBITIS 39 0.0076
503 DRUG INEFFECTIVE 10034 0.0076
504 RHINORRHOEA 490 0.0076
505 PRE-ECLAMPSIA 36 0.0076
506 RIB FRACTURE 155 0.0075
507 SLEEP DISORDER 529 0.0075
508 GASTROINTESTINAL CARCINOMA 68 0.0075
509 HERPES ZOSTER 427 0.0074
510 DRUG INTOLERANCE 716 0.0074
511 VARICOSE VEIN 38 0.0074
512 PRODUCTIVE COUGH 350 0.0073
513 PANCREATIC DISORDER 36 0.0073
514 VASCULITIS 85 0.0073
515 ARTHROPOD BITE 54 0.0073
516 BLOOD TEST ABNORMAL 102 0.0073
517 LIMB INJURY 197 0.0072
518 DEEP VEIN THROMBOSIS 469 0.0072
519 HIATUS HERNIA 93 0.0072
520 MUSCULOSKELETAL PAIN 376 0.0072
521 RESPIRATORY TRACT CONGESTION 114 0.0072
522 URINARY TRACT INFECTION 1220 0.0071
523 ACCIDENT 85 0.0071
524 DEHYDRATION 949 0.0071
525 WRIST FRACTURE 85 0.0071
526 LIGAMENT SPRAIN 70 0.0071
527 ANKLE FRACTURE 109 0.0070
528 CONTRAINDICATED PRODUCT ADMINISTERED 213 0.0070
529 FOETAL DEATH 36 0.0069
530 WEIGHT INCREASED 1553 0.0069
531 FEELING COLD 193 0.0069
532 MUSCULOSKELETAL CHEST PAIN 107 0.0069
533 INCONTINENCE 73 0.0069
534 TREATMENT NONCOMPLIANCE 376 0.0069
535 SWOLLEN TONGUE 213 0.0068
536 HAEMOGLOBIN DECREASED 698 0.0068
537 MULTIPLE ALLERGIES 53 0.0068
538 DERMATITIS ACNEIFORM 41 0.0067
539 INTERVERTEBRAL DISC PROTRUSION 147 0.0067
540 HYPOAESTHESIA 999 0.0067
541 VITAMIN D DECREASED 57 0.0067
542 HEADACHE 4163 0.0066
543 APPETITE DISORDER 44 0.0066
544 INTENTIONAL PRODUCT USE ISSUE 581 0.0066
545 DEMENTIA 184 0.0066
546 ECZEMA 344 0.0066
547 LEUKAEMIA 62 0.0066
548 PROCEDURAL COMPLICATION 50 0.0065
549 MUSCULOSKELETAL DISCOMFORT 112 0.0065
550 OESOPHAGITIS 71 0.0065
551 WHITE BLOOD CELL COUNT INCREASED 248 0.0065
552 IMMUNOSUPPRESSION 57 0.0065
553 CONDITION AGGRAVATED 1962 0.0064
554 CARPAL TUNNEL SYNDROME 90 0.0064
555 CONFUSIONAL STATE 1037 0.0064
556 BREAST MASS 43 0.0064
557 NEOPLASM MALIGNANT 423 0.0063
558 ASTHENIA 2382 0.0063
559 LYMPHADENOPATHY 224 0.0063
560 ALOPECIA 1241 0.0063
561 BRAIN NEOPLASM 58 0.0063
562 AORTIC ANEURYSM 48 0.0063
563 GINGIVITIS 34 0.0063
564 RASH PRURITIC 341 0.0063
565 MENINGITIS 42 0.0063
566 HIP FRACTURE 202 0.0063
567 MEDICATION ERROR 349 0.0063
568 VERTIGO 382 0.0063
569 HIDRADENITIS 57 0.0062
570 METASTASES TO LYMPH NODES 42 0.0062
571 GALLBLADDER DISORDER 111 0.0062
572 SINUS CONGESTION 84 0.0062
573 PNEUMONIA BACTERIAL 57 0.0062
574 PULMONARY EMBOLISM 590 0.0062
575 ORAL HERPES 121 0.0062
576 SWELLING 580 0.0062
577 CHEST PAIN 1147 0.0062
578 BLOOD PRESSURE FLUCTUATION 148 0.0062
579 RHEUMATOID ARTHRITIS 700 0.0062
580 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 105 0.0061
581 SKIN LESION 168 0.0061
582 SPUTUM DISCOLOURED 58 0.0061
583 ADVERSE DRUG REACTION 544 0.0061
584 FLUID RETENTION 308 0.0060
585 ANAEMIA 1148 0.0060
586 SKIN MASS 40 0.0060
587 HAEMORRHAGE 623 0.0060
588 BACK PAIN 1383 0.0059
589 COVID-19 PNEUMONIA 70 0.0059
590 FOOT FRACTURE 112 0.0059
591 URTICARIA 988 0.0059
592 BACTERIAL INFECTION 110 0.0059
593 ENTEROCOLITIS 34 0.0059
594 UPPER LIMB FRACTURE 117 0.0059
595 OROPHARYNGEAL DISCOMFORT 53 0.0059
596 NAIL DISORDER 51 0.0058
597 BLOOD PRESSURE DIASTOLIC DECREASED 43 0.0058
598 VOMITING 2738 0.0058
599 HEAD DISCOMFORT 103 0.0058
600 GASTRITIS 153 0.0058
601 THERAPEUTIC RESPONSE DECREASED 352 0.0058
602 HYPOALBUMINAEMIA 45 0.0058
603 ILL-DEFINED DISORDER 351 0.0058
604 PAIN IN EXTREMITY 1697 0.0058
605 RENAL PAIN 61 0.0057
606 SENSORY LOSS 46 0.0057
607 GASTROOESOPHAGEAL REFLUX DISEASE 460 0.0057
608 DEVICE DEFECTIVE 99 0.0057
609 COELIAC DISEASE 56 0.0057
610 INFUSION SITE ERYTHEMA 48 0.0057
611 BLOOD POTASSIUM DECREASED 171 0.0057
612 TINNITUS 261 0.0057
613 PRODUCT PREPARATION ISSUE 37 0.0056
614 OSTEOMYELITIS 102 0.0056
615 GOUT 101 0.0056
616 ULCER HAEMORRHAGE 38 0.0056
617 CYST 69 0.0056
618 HYPERSENSITIVITY 1023 0.0055
619 MYOCARDITIS 63 0.0055
620 RASH PUSTULAR 40 0.0055
621 PERIPHERAL COLDNESS 75 0.0055
622 CHILLS 640 0.0055
623 RASH PAPULAR 122 0.0054
624 RESPIRATORY TRACT INFECTION 141 0.0054
625 FACIAL PARALYSIS 46 0.0054
626 NERVE INJURY 60 0.0054
627 PELVIC FRACTURE 42 0.0054
628 FEELING HOT 329 0.0054
629 NAUSEA 4215 0.0053
630 NIGHTMARE 182 0.0053
631 MEMORY IMPAIRMENT 722 0.0052
632 POST PROCEDURAL HAEMORRHAGE 61 0.0052
633 SEPSIS 581 0.0052
634 UROSEPSIS 48 0.0052
635 ADVERSE EVENT 474 0.0051
636 SPINAL FRACTURE 103 0.0051
637 ABNORMAL LOSS OF WEIGHT 35 0.0051
638 COUGH 1431 0.0051
639 JOINT INJURY 109 0.0051
640 IMMUNODEFICIENCY 76 0.0051
641 MUSCULAR WEAKNESS 578 0.0051
642 BREAST CANCER STAGE I 47 0.0051
643 TOOTHACHE 91 0.0050
644 RASH MACULAR 175 0.0050
645 RETINAL DETACHMENT 46 0.0050
646 ACCIDENTAL OVERDOSE 183 0.0050
647 OEDEMA PERIPHERAL 608 0.0050
648 FEEDING DISORDER 101 0.0050
649 HEART RATE IRREGULAR 112 0.0050
650 ADRENAL INSUFFICIENCY 60 0.0049
651 PANCREATITIS ACUTE 111 0.0049
652 OXYGEN SATURATION DECREASED 277 0.0049
653 ELECTROLYTE IMBALANCE 57 0.0049
654 MYALGIA 833 0.0049
655 LUNG NEOPLASM MALIGNANT 200 0.0049
656 OCULAR DISCOMFORT 54 0.0048
657 EOSINOPHIL COUNT INCREASED 40 0.0048
658 HAEMOLYTIC ANAEMIA 43 0.0048
659 DEPRESSED MOOD 253 0.0048
660 SQUAMOUS CELL CARCINOMA 45 0.0048
661 SINUS DISORDER 94 0.0047
662 PRODUCT PREPARATION ERROR 97 0.0047
663 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41 0.0047
664 DEVICE LEAKAGE 204 0.0047
665 MENTAL DISORDER 204 0.0047
666 GASTRIC ULCER 89 0.0047
667 EOSINOPHILIA 82 0.0047
668 HEAD INJURY 148 0.0047
669 CORONARY ARTERY OCCLUSION 64 0.0047
670 APHONIA 65 0.0047
671 HYPERTENSION 986 0.0047
672 TRANSIENT ISCHAEMIC ATTACK 157 0.0046
673 MUSCLE SPASMS 851 0.0046
674 CHOLECYSTITIS 55 0.0046
675 SKIN REACTION 65 0.0046
676 PSORIASIS 601 0.0046
677 BODY HEIGHT DECREASED 49 0.0046
678 CONJUNCTIVITIS 85 0.0046
679 KNEE OPERATION 45 0.0046
680 BLOOD URINE PRESENT 86 0.0045
681 SPLENOMEGALY 53 0.0045
682 STAPHYLOCOCCAL INFECTION 149 0.0045
683 DIABETES MELLITUS 344 0.0045
684 PRODUCT STORAGE ERROR 395 0.0045
685 NECK PAIN 252 0.0045
686 HYSTERECTOMY 39 0.0045
687 NEUTROPHIL COUNT INCREASED 46 0.0045
688 PAIN 2747 0.0045
689 LIMB DISCOMFORT 138 0.0045
690 INCREASED TENDENCY TO BRUISE 41 0.0045
691 PERITONITIS 92 0.0044
692 BLADDER DISORDER 44 0.0044
693 DIZZINESS 2209 0.0044
694 BLOOD PRESSURE ABNORMAL 88 0.0044
695 RENAL CYST 35 0.0044
696 PALPITATIONS 516 0.0044
697 FOOD ALLERGY 34 0.0044
698 BACTERAEMIA 52 0.0044
699 DEPRESSION 996 0.0044
700 ASTHMA 492 0.0043
701 NEOPLASM 50 0.0043
702 THROMBOSIS 349 0.0043
703 FALL 1442 0.0043
704 EPILEPSY 132 0.0043
705 RESPIRATORY DISORDER 129 0.0043
706 PHOTOPHOBIA 81 0.0043
707 RASH 1871 0.0043
708 UPPER-AIRWAY COUGH SYNDROME 35 0.0042
709 TACHYCARDIA 372 0.0042
710 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 71 0.0042
711 ANXIETY 1187 0.0042
712 HAEMATOCRIT DECREASED 82 0.0041
713 DIZZINESS POSTURAL 40 0.0041
714 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 34 0.0041
715 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 214 0.0041
716 TENDONITIS 63 0.0041
717 BLOOD PRESSURE SYSTOLIC INCREASED 79 0.0040
718 SENSATION OF FOREIGN BODY 34 0.0040
719 MICTURITION URGENCY 46 0.0040
720 CHEST DISCOMFORT 412 0.0040
721 HEAVY MENSTRUAL BLEEDING 36 0.0040
722 COLD SWEAT 70 0.0040
723 SKIN DISORDER 132 0.0040
724 DEVICE MALFUNCTION 278 0.0040
725 MULTIPLE ORGAN DYSFUNCTION SYNDROME 112 0.0039
726 PARAESTHESIA 622 0.0039
727 VISUAL IMPAIRMENT 489 0.0039
728 DYSURIA 145 0.0039
729 HYPERTHYROIDISM 57 0.0039
730 BLOOD CALCIUM DECREASED 44 0.0039
731 LETHARGY 225 0.0039
732 ACNE 296 0.0039
733 TOOTH FRACTURE 43 0.0039
734 NERVE COMPRESSION 36 0.0039
735 PRODUCT USE ISSUE 728 0.0039
736 SKIN ULCER 100 0.0039
737 EMPHYSEMA 39 0.0039
738 MELAENA 85 0.0039
739 PNEUMOTHORAX 61 0.0038
740 MASS 53 0.0038
741 SUPRAVENTRICULAR TACHYCARDIA 36 0.0038
742 SNEEZING 84 0.0037
743 SEASONAL ALLERGY 53 0.0037
744 DRY THROAT 38 0.0037
745 GAIT DISTURBANCE 705 0.0037
746 HYPOAESTHESIA ORAL 55 0.0036
747 GLAUCOMA 70 0.0036
748 EXPOSURE DURING PREGNANCY 225 0.0036
749 PRURITUS 1389 0.0036
750 CEREBROVASCULAR ACCIDENT 610 0.0036
751 INTERNAL HAEMORRHAGE 41 0.0036
752 SYNCOPE 359 0.0036
753 SPINAL PAIN 42 0.0036
754 MATERNAL EXPOSURE DURING PREGNANCY 318 0.0036
755 RASH ERYTHEMATOUS 170 0.0036
756 NEURALGIA 86 0.0035
757 INJECTION SITE DISCOMFORT 37 0.0035
758 SCAR 60 0.0035
759 DYSPNOEA EXERTIONAL 132 0.0035
760 THYROID DISORDER 54 0.0035
761 THROAT IRRITATION 157 0.0035
762 EYE DISCHARGE 36 0.0035
763 ANAPHYLACTIC REACTION 191 0.0035
764 INSOMNIA 917 0.0034
765 HEPATITIS 88 0.0034
766 DYSGEUSIA 255 0.0034
767 DYSPNOEA 1935 0.0034
768 OBSTRUCTIVE AIRWAYS DISORDER 38 0.0034
769 EAR DISCOMFORT 35 0.0034
770 DEAFNESS 89 0.0034
771 IMPAIRED GASTRIC EMPTYING 46 0.0034
772 NERVOUSNESS 176 0.0034
773 DRY MOUTH 273 0.0034
774 VISION BLURRED 461 0.0034
775 SLEEP APNOEA SYNDROME 64 0.0034
776 ERYTHEMA 683 0.0033
777 ADVERSE REACTION 44 0.0033
778 CANDIDA INFECTION 56 0.0033
779 PRODUCT PRESCRIBING ISSUE 71 0.0033
780 TASTE DISORDER 66 0.0032
781 SCAB 37 0.0032
782 NODULE 42 0.0032
783 METASTASES TO LIVER 56 0.0032
784 HYPOACUSIS 137 0.0032
785 HYPERSOMNIA 91 0.0032
786 SPINAL OPERATION 39 0.0032
787 ASCITES 93 0.0032
788 LIVER FUNCTION TEST ABNORMAL 92 0.0032
789 OSTEOPENIA 48 0.0032
790 PERICARDIAL EFFUSION 73 0.0032
791 FUNGAL INFECTION 105 0.0031
792 METASTASES TO LUNG 36 0.0031
793 TOOTH DISORDER 69 0.0031
794 ANAPHYLACTIC SHOCK 80 0.0031
795 ERUCTATION 59 0.0030
796 JAUNDICE 82 0.0030
797 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 167 0.0030
798 SEPTIC SHOCK 131 0.0030
799 EATING DISORDER 64 0.0030
800 TENDON RUPTURE 37 0.0030
801 THROAT TIGHTNESS 81 0.0030
802 THYROID CANCER 36 0.0030
803 DERMATITIS CONTACT 34 0.0030
804 INJECTION SITE REACTION 205 0.0030
805 INTRAOCULAR PRESSURE INCREASED 38 0.0030
806 HYPERHIDROSIS 383 0.0030
807 PHOTOSENSITIVITY REACTION 49 0.0030
808 HAEMATEMESIS 75 0.0030
809 SARS-COV-2 TEST POSITIVE 39 0.0030
810 SOMNOLENCE 593 0.0029
811 INCORRECT DOSE ADMINISTERED 668 0.0029
812 FEELING ABNORMAL 700 0.0029
813 LOSS OF CONSCIOUSNESS 374 0.0029
814 EYE SWELLING 108 0.0029
815 SWELLING FACE 188 0.0029
816 HOT FLUSH 217 0.0029
817 PRESYNCOPE 70 0.0029
818 ATRIAL FIBRILLATION 278 0.0029
819 PRODUCT USE IN UNAPPROVED INDICATION 706 0.0028
820 ARRHYTHMIA 134 0.0028
821 PNEUMONITIS 77 0.0028
822 BLOOD ALKALINE PHOSPHATASE INCREASED 70 0.0028
823 RENAL DISORDER 131 0.0028
824 MULTIPLE SCLEROSIS 133 0.0028
825 BALANCE DISORDER 239 0.0028
826 MUSCLE ATROPHY 35 0.0028
827 ANGINA PECTORIS 79 0.0028
828 GAMMA-GLUTAMYLTRANSFERASE INCREASED 61 0.0027
829 INJECTION SITE PRURITUS 184 0.0027
830 METASTASES TO BONE 45 0.0027
831 HYPOTHYROIDISM 87 0.0027
832 DERMATITIS 57 0.0027
833 PLEURAL EFFUSION 164 0.0027
834 LABORATORY TEST ABNORMAL 78 0.0026
835 THIRST 47 0.0026
836 HYPOKALAEMIA 121 0.0026
837 PROSTATE CANCER 210 0.0026
838 ORAL PAIN 58 0.0026
839 RED BLOOD CELL COUNT DECREASED 74 0.0026
840 INCORRECT PRODUCT STORAGE 34 0.0026
841 BEDRIDDEN 34 0.0026
842 DYSPHONIA 151 0.0026
843 URINARY RETENTION 85 0.0025
844 BLOOD SODIUM DECREASED 48 0.0025
845 POLLAKIURIA 106 0.0025
846 RETCHING 54 0.0025
847 BURNING SENSATION 176 0.0025
848 DISTURBANCE IN ATTENTION 135 0.0025
849 THERAPEUTIC RESPONSE SHORTENED 83 0.0025
850 INCORRECT PRODUCT ADMINISTRATION DURATION 54 0.0025
851 DRUG LEVEL INCREASED 41 0.0025
852 PRODUCT PRESCRIBING ERROR 59 0.0025
853 PANIC ATTACK 90 0.0025
854 DEATH 2122 0.0025
855 RENAL IMPAIRMENT 206 0.0024
856 CARDIAC DISORDER 229 0.0024
857 INJECTION SITE RASH 75 0.0024
858 HUNGER 34 0.0024
859 INTERSTITIAL LUNG DISEASE 118 0.0024
860 PULMONARY OEDEMA 109 0.0024
861 LYMPHOCYTE COUNT DECREASED 43 0.0024
862 DIPLOPIA 63 0.0024
863 BLINDNESS UNILATERAL 34 0.0024
864 EYE PAIN 136 0.0024
865 INJECTION SITE SWELLING 184 0.0024
866 URINARY INCONTINENCE 71 0.0024
867 HEPATIC FAILURE 72 0.0024
868 SEIZURE 274 0.0024
869 HEPATIC CANCER 57 0.0024
870 PELVIC PAIN 43 0.0024
871 INSURANCE ISSUE 36 0.0024
872 DRY EYE 117 0.0023
873 LEUKOCYTOSIS 42 0.0023
874 MENTAL IMPAIRMENT 56 0.0023
875 GASTROINTESTINAL HAEMORRHAGE 192 0.0023
876 FOETAL EXPOSURE DURING PREGNANCY 186 0.0023
877 BLOOD POTASSIUM INCREASED 37 0.0023
878 BONE PAIN 133 0.0023
879 EYE DISORDER 74 0.0022
880 FLUSHING 228 0.0022
881 INJECTION SITE URTICARIA 55 0.0022
882 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 158 0.0022
883 LUNG INFECTION 34 0.0022
884 APHASIA 66 0.0022
885 OCULAR HYPERAEMIA 103 0.0022
886 INJECTION SITE PAIN 659 0.0021
887 MYOCARDIAL INFARCTION 374 0.0021
888 DRUG RESISTANCE 55 0.0021
889 CHROMATURIA 48 0.0021
890 CARDIAC FAILURE 170 0.0021
891 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
892 EYE PRURITUS 70 0.0021
893 CHOLESTASIS 40 0.0021
894 PREMATURE BABY 62 0.0021
895 PAIN IN JAW 58 0.0020
896 LIP SWELLING 68 0.0020
897 SKIN DISCOLOURATION 93 0.0020
898 HEMIPARESIS 34 0.0020
899 FEMUR FRACTURE 61 0.0020
900 COGNITIVE DISORDER 90 0.0019
901 LACRIMATION INCREASED 58 0.0019
902 INJECTION SITE ERYTHEMA 235 0.0019
903 INJECTION SITE BRUISING 151 0.0019
904 SPEECH DISORDER 98 0.0019
905 UNDERDOSE 135 0.0018
906 ALANINE AMINOTRANSFERASE INCREASED 113 0.0018
907 RENAL FAILURE 244 0.0018
908 TREMOR 299 0.0018
909 RASH GENERALISED 46 0.0018
910 ANGER 60 0.0018
911 BLINDNESS 72 0.0018
912 INJECTION SITE MASS 65 0.0018
913 HAEMATURIA 60 0.0018
914 PRODUCT DISPENSING ERROR 38 0.0017
915 CHOKING 34 0.0017
916 OSTEONECROSIS 57 0.0017
917 UNEVALUABLE EVENT 131 0.0017
918 PANCREATIC CARCINOMA 50 0.0017
919 DISEASE RECURRENCE 82 0.0017
920 TRANSAMINASES INCREASED 38 0.0017
921 ACUTE KIDNEY INJURY 254 0.0017
922 DYSPHAGIA 156 0.0016
923 BLOOD BILIRUBIN INCREASED 44 0.0016
924 BLADDER CANCER 94 0.0016
925 DRY SKIN 212 0.0016
926 BRADYCARDIA 84 0.0016
927 PNEUMONIA ASPIRATION 39 0.0016
928 NEUROPATHY PERIPHERAL 148 0.0016
929 CORONARY ARTERY DISEASE 47 0.0016
930 BLOOD CREATININE INCREASED 101 0.0015
931 NERVOUS SYSTEM DISORDER 48 0.0015
932 AGEUSIA 38 0.0015
933 DISORIENTATION 59 0.0015
934 HAEMATOMA 38 0.0015
935 THROMBOCYTOPENIA 163 0.0015
936 EPISTAXIS 106 0.0014
937 CARDIAC FAILURE CONGESTIVE 113 0.0014
938 CEREBRAL HAEMORRHAGE 50 0.0014
939 HYPOTENSION 279 0.0014
940 ACUTE MYOCARDIAL INFARCTION 41 0.0014
941 SKIN IRRITATION 63 0.0014
942 EMOTIONAL DISORDER 42 0.0014
943 EYE IRRITATION 77 0.0013
944 ANGIOEDEMA 59 0.0013
945 HAEMOPTYSIS 37 0.0013
946 MOOD ALTERED 36 0.0013
947 VAGINAL HAEMORRHAGE 55 0.0013
948 BREAST CANCER 118 0.0013
949 DEVICE ISSUE 113 0.0013
950 PRODUCT DOSE OMISSION 82 0.0013
951 INCORRECT DRUG ADMINISTRATION DURATION 35 0.0012
952 RENAL CANCER 59 0.0012
953 OESOPHAGEAL CARCINOMA 36 0.0012
954 RESPIRATORY FAILURE 87 0.0012
955 SUICIDAL IDEATION 109 0.0012
956 ASPARTATE AMINOTRANSFERASE INCREASED 62 0.0012
957 DRUG EFFECT DECREASED 62 0.0011
958 LEUKOPENIA 57 0.0011
959 DYSARTHRIA 42 0.0011
960 DRUG EFFECT INCOMPLETE 40 0.0011
961 PANCYTOPENIA 61 0.0011
962 CARDIAC ARREST 90 0.0011
963 INJECTION SITE HAEMORRHAGE 86 0.0011
964 IRRITABILITY 64 0.0011
965 THERAPY CESSATION 54 0.0011
966 SKIN EXFOLIATION 87 0.0010
967 BLOOD GLUCOSE DECREASED 49 0.0010
968 WHITE BLOOD CELL COUNT DECREASED 110 0.0010
969 HYPOGLYCAEMIA 49 0.0010
970 CRYING 35 0.0010
971 RESTLESSNESS 34 0.0009
972 BLOOD GLUCOSE INCREASED 169 0.0009
973 PLATELET COUNT DECREASED 94 0.0009
974 CHRONIC KIDNEY DISEASE 66 0.0009
975 COMA 41 0.0009
976 EMOTIONAL DISTRESS 102 0.0008
977 COLORECTAL CANCER 37 0.0008
978 HYPONATRAEMIA 37 0.0007
979 AGITATION 47 0.0006
980 DRUG DOSE OMISSION 105 0.0006
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 125 0.0006
982 NEUTROPENIA 83 0.0006
983 DISEASE PROGRESSION 71 0.0006
984 DRUG INTERACTION 88 0.0006
985 SKIN BURNING SENSATION 39 0.0005
986 INTENTIONAL PRODUCT MISUSE 41 0.0005
987 DRUG DEPENDENCE 71 0.0004
988 PRODUCT QUALITY ISSUE 58 0.0004
989 OVERDOSE 71 0.0003